-
Product Insights
NewCoagulation Factor VIII – Drugs In Development, 2024
The Coagulation Factor VIII pipeline drugs market research report outlays comprehensive information on the Coagulation Factor VIII targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Hemophilia A (Factor VIII Deficiency), Von Willebrand Disease (vWD), Venous Thromboembolism, Acute Ischemic Stroke, Alzheimer's Disease, Amyotrophic Lateral Sclerosis,...
-
Product Insights
NewSignal Transducer And Activator Of Transcription 3 – Drugs In Development, 2024
The Signal Transducer And Activator Of Transcription 3 pipeline drugs market research report outlays comprehensive information on the Signal Transducer And Activator Of Transcription 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Central Nervous System, and Gastrointestinal which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Rheumatoid Arthritis, Inflammation, Multiple Sclerosis, Alcohol Dependence,...
-
Product Insights
NewDipeptidyl Peptidase 4 – Drugs In Development, 2024
The Dipeptidyl Peptidase 4 pipeline drugs market research report outlays comprehensive information on the Dipeptidyl Peptidase 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Ophthalmology, and Undisclosed which include indications of Type 2 Diabetes, Diabetes, Cardiovascular Disease, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), Diabetic Retinopathy, Glaucoma, and Unspecified. It also reviews...
-
Product Insights
NewToll Like Receptor 7 – Drugs In Development, 2024
The Toll Like Receptor 7 pipeline drugs market research report outlays comprehensive information on the Toll Like Receptor 7 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, Immunology, and Dermatology which include indications of Solid Tumor, Melanoma, Human Immunodeficiency Virus (HIV) Infections (AIDS), Hepatitis B, Systemic Lupus Erythematosus, Inflammation, Dermatological Disorders, and Actinic (Solar)...
-
Product Insights
NewT Cell Immunoreceptor With Ig And ITIM Domains – Drugs In Development, 2024
The T Cell Immunoreceptor With Ig And ITIM Domains pipeline drugs market research report outlays comprehensive information on the T Cell Immunoreceptor With Ig And ITIM Domains targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Undisclosed which include indications of Solid Tumor, Non-Small Cell Lung Cancer, and Unspecified. It also reviews key players involved in...
-
Product Insights
NewCyclin Dependent Kinase 4 – Drugs In Development, 2024
The Cyclin Dependent Kinase 4 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Kinase 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Toxicology, Infectious Disease, and Genetic Disorders which include indications of Solid Tumor, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Chemotherapy Induced Myelosuppression, Chemotherapy-Induced Diarrhea...
-
Product Insights
NewFibroblast Growth Factor Receptor 1 – Drugs In Development, 2024
The Fibroblast Growth Factor Receptor 1 pipeline drugs market research report outlays comprehensive information on the Fibroblast Growth Factor Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Gastrointestinal, Metabolic Disorders, and Respiratory which include indications of Solid Tumor, Bile Duct Cancer (Cholangiocarcinoma) , Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Type...
-
Product Insights
NewTyrosine Protein Kinase JAK1 – Drugs In Development, 2024
The Tyrosine Protein Kinase JAK1 pipeline drugs market research report outlays comprehensive information on the Tyrosine Protein Kinase JAK1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Dermatology, Gastrointestinal, and Oncology which include indications of Rheumatoid Arthritis, Psoriasis, Atopic Dermatitis (Atopic Eczema), Alopecia Areata, Ulcerative Colitis, Inflammatory Bowel Disease, Myelofibrosis, and Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)....
-
Product Insights
NewMacrophage Colony Stimulating Factor 1 Receptor – Drugs In Development, 2024
The Macrophage Colony Stimulating Factor 1 Receptor pipeline drugs market research report outlays comprehensive information on the Macrophage Colony Stimulating Factor 1 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Immunology, and Musculoskeletal Disorders which include indications of Solid Tumor, Colorectal Cancer, Amyotrophic Lateral Sclerosis, Neuroinflammation, Graft Versus Host Disease (GVHD), Inflammation,...
-
Product Insights
NewInterferon Alpha/Beta Receptor 1 – Drugs In Development, 2024
The Interferon Alpha/Beta Receptor 1 pipeline drugs market research report outlays comprehensive information on the Interferon Alpha/Beta Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Respiratory, and Central Nervous System which include indications of Coronavirus Disease 2019 (COVID-19), Hepatitis B, Oncology, Solid Tumor, Pneumonia, Acute Respiratory Distress Syndrome, Multiple Sclerosis, and Demyelinating...